Study for ongoing symptoms after COVID-19
Part of Infections, Lungs & breathing clinical trials.
This trial studies people with mild to moderate COVID-19 symptoms to better understand and help “post-COVID” condition (ongoing effects after infection). You may be eligible if you’re an adult with a recent confirmed COVID-19 test and you agreed to take part.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years
- Have had a positive COVID-19 test (SARS-CoV-2) from a nose/throat or upper breathing sample
- Had COVID-19 that was mild (no hospital stay) or moderate/severe enough to require hospital care
- Be willing to sign the study consent form
- Not have died during hospitalization
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who are in the hospital (including the emergency ward) with a confirmed COVID-19 infection. It aims to learn how COVID-19 affects people in the hospital and how different cases may differ over time.
This study looks at how COVID-19 can affect health and quality of life over the long term. It may help researchers understand symptoms that can last and what changes people experience after recovery.
This study looks at what factors may make COVID-19 symptoms or infection effects last after someone has recovered. It also collects certain body samples to better understand why this persistence happens.
This study looks at how the body's immune system reacted to COVID-19 in people who had either severe or mild cases. The goal is to learn more about a specific part of the immune response (called IFN-I) to better understand the disease.
This study follows people in Shanghai who have tested positive for the COVID virus, even if they have no symptoms yet. It helps doctors understand what happens after infection and in people who later get a diagnosis.
This study looks closely at how your immune system responds during COVID-19. It may help researchers better understand why COVID-19 varies from person to person and how to improve future care.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.